Stem Cell Treatments Market, Global Outlook and Forecast 2022-2028

April 2022 | 66 pages | ID: S81AAB0A3135EN
Market Monitor Global

Abstracts

Stem Cell Treatment is a method of transplanting healthy stem cells into a patient to repair or replace damaged cells or tissues, thereby achieving the goal of healing. Stem cell transplantation has a wide range of treatments, and can generally treat neurological diseases, immune system diseases, and other medical and surgical diseases.

This report contains market size and forecasts of Stem Cell Treatments in Global, including the following market information:

Global Stem Cell Treatments Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Stem Cell Treatments market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Adipose Tissue-Derived Mesenchymal Stem Cells Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Stem Cell Treatments include Osiris Therapeutics, Inc, MEDIPOST Co., Ltd, JCR Pharmaceuticals Co., Ltd, FUJIFILM Cellular Dynamics, Inc., Holostem Terapie Avanzate S.r.l., Athersys Inc., CORESTEM, Inc, Mesoblast Ltd. and Regenexx, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Stem Cell Treatments companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Stem Cell Treatments Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Stem Cell Treatments Market Segment Percentages, by Type, 2021 (%)

• Adipose Tissue-Derived Mesenchymal Stem Cells
• Bone Marrow-Derived Mesenchymal Stem Cells
• Cord Blood/Embryonic Stem Cells
• Other Cell Sources

Global Stem Cell Treatments Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Stem Cell Treatments Market Segment Percentages, by Application, 2021 (%)

• Nerve Diseases
• Immunological Diseases
• Musculoskeletal Disorders
• Cardiovascular Diseases
• Gastrointestinal Diseases
• Other

Global Stem Cell Treatments Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Stem Cell Treatments Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Stem Cell Treatments revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Stem Cell Treatments revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Osiris Therapeutics, Inc
• MEDIPOST Co., Ltd
• JCR Pharmaceuticals Co., Ltd
• FUJIFILM Cellular Dynamics, Inc.
• Holostem Terapie Avanzate S.r.l.
• Athersys Inc.
• CORESTEM, Inc
• Mesoblast Ltd.
• Regenexx
• Reliance Life Sciences Private Limited
• U.S. Stem Cell, Inc.
• Vericel Corporation
• Pharmicell Co., Ltd

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Stem Cell Treatments Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Stem Cell Treatments Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL STEM CELL TREATMENTS OVERALL MARKET SIZE

2.1 Global Stem Cell Treatments Market Size: 2021 VS 2028
2.2 Global Stem Cell Treatments Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Stem Cell Treatments Players in Global Market
3.2 Top Global Stem Cell Treatments Companies Ranked by Revenue
3.3 Global Stem Cell Treatments Revenue by Companies
3.4 Top 3 and Top 5 Stem Cell Treatments Companies in Global Market, by Revenue in 2021
3.5 Global Companies Stem Cell Treatments Product Type
3.6 Tier 1, Tier 2 and Tier 3 Stem Cell Treatments Players in Global Market
  3.6.1 List of Global Tier 1 Stem Cell Treatments Companies
  3.6.2 List of Global Tier 2 and Tier 3 Stem Cell Treatments Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Stem Cell Treatments Market Size Markets, 2021 & 2028
  4.1.2 Adipose Tissue-Derived Mesenchymal Stem Cells
  4.1.3 Bone Marrow-Derived Mesenchymal Stem Cells
  4.1.4 Cord Blood/Embryonic Stem Cells
  4.1.5 Other Cell Sources
4.2 By Type - Global Stem Cell Treatments Revenue & Forecasts
  4.2.1 By Type - Global Stem Cell Treatments Revenue, 2017-2022
  4.2.2 By Type - Global Stem Cell Treatments Revenue, 2023-2028
  4.2.3 By Type - Global Stem Cell Treatments Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Stem Cell Treatments Market Size, 2021 & 2028
  5.1.2 Nerve Diseases
  5.1.3 Immunological Diseases
  5.1.4 Musculoskeletal Disorders
  5.1.5 Cardiovascular Diseases
  5.1.6 Gastrointestinal Diseases
  5.1.7 Other
5.2 By Application - Global Stem Cell Treatments Revenue & Forecasts
  5.2.1 By Application - Global Stem Cell Treatments Revenue, 2017-2022
  5.2.2 By Application - Global Stem Cell Treatments Revenue, 2023-2028
  5.2.3 By Application - Global Stem Cell Treatments Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Stem Cell Treatments Market Size, 2021 & 2028
6.2 By Region - Global Stem Cell Treatments Revenue & Forecasts
  6.2.1 By Region - Global Stem Cell Treatments Revenue, 2017-2022
  6.2.2 By Region - Global Stem Cell Treatments Revenue, 2023-2028
  6.2.3 By Region - Global Stem Cell Treatments Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Stem Cell Treatments Revenue, 2017-2028
  6.3.2 US Stem Cell Treatments Market Size, 2017-2028
  6.3.3 Canada Stem Cell Treatments Market Size, 2017-2028
  6.3.4 Mexico Stem Cell Treatments Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Stem Cell Treatments Revenue, 2017-2028
  6.4.2 Germany Stem Cell Treatments Market Size, 2017-2028
  6.4.3 France Stem Cell Treatments Market Size, 2017-2028
  6.4.4 U.K. Stem Cell Treatments Market Size, 2017-2028
  6.4.5 Italy Stem Cell Treatments Market Size, 2017-2028
  6.4.6 Russia Stem Cell Treatments Market Size, 2017-2028
  6.4.7 Nordic Countries Stem Cell Treatments Market Size, 2017-2028
  6.4.8 Benelux Stem Cell Treatments Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Stem Cell Treatments Revenue, 2017-2028
  6.5.2 China Stem Cell Treatments Market Size, 2017-2028
  6.5.3 Japan Stem Cell Treatments Market Size, 2017-2028
  6.5.4 South Korea Stem Cell Treatments Market Size, 2017-2028
  6.5.5 Southeast Asia Stem Cell Treatments Market Size, 2017-2028
  6.5.6 India Stem Cell Treatments Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Stem Cell Treatments Revenue, 2017-2028
  6.6.2 Brazil Stem Cell Treatments Market Size, 2017-2028
  6.6.3 Argentina Stem Cell Treatments Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Stem Cell Treatments Revenue, 2017-2028
  6.7.2 Turkey Stem Cell Treatments Market Size, 2017-2028
  6.7.3 Israel Stem Cell Treatments Market Size, 2017-2028
  6.7.4 Saudi Arabia Stem Cell Treatments Market Size, 2017-2028
  6.7.5 UAE Stem Cell Treatments Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Osiris Therapeutics, Inc
  7.1.1 Osiris Therapeutics, Inc Corporate Summary
  7.1.2 Osiris Therapeutics, Inc Business Overview
  7.1.3 Osiris Therapeutics, Inc Stem Cell Treatments Major Product Offerings
  7.1.4 Osiris Therapeutics, Inc Stem Cell Treatments Revenue in Global Market (2017-2022)
  7.1.5 Osiris Therapeutics, Inc Key News
7.2 MEDIPOST Co., Ltd
  7.2.1 MEDIPOST Co., Ltd Corporate Summary
  7.2.2 MEDIPOST Co., Ltd Business Overview
  7.2.3 MEDIPOST Co., Ltd Stem Cell Treatments Major Product Offerings
  7.2.4 MEDIPOST Co., Ltd Stem Cell Treatments Revenue in Global Market (2017-2022)
  7.2.5 MEDIPOST Co., Ltd Key News
7.3 JCR Pharmaceuticals Co., Ltd
  7.3.1 JCR Pharmaceuticals Co., Ltd Corporate Summary
  7.3.2 JCR Pharmaceuticals Co., Ltd Business Overview
  7.3.3 JCR Pharmaceuticals Co., Ltd Stem Cell Treatments Major Product Offerings
  7.3.4 JCR Pharmaceuticals Co., Ltd Stem Cell Treatments Revenue in Global Market (2017-2022)
  7.3.5 JCR Pharmaceuticals Co., Ltd Key News
7.4 FUJIFILM Cellular Dynamics, Inc.
  7.4.1 FUJIFILM Cellular Dynamics, Inc. Corporate Summary
  7.4.2 FUJIFILM Cellular Dynamics, Inc. Business Overview
  7.4.3 FUJIFILM Cellular Dynamics, Inc. Stem Cell Treatments Major Product Offerings
  7.4.4 FUJIFILM Cellular Dynamics, Inc. Stem Cell Treatments Revenue in Global Market (2017-2022)
  7.4.5 FUJIFILM Cellular Dynamics, Inc. Key News
7.5 Holostem Terapie Avanzate S.r.l.
  7.5.1 Holostem Terapie Avanzate S.r.l. Corporate Summary
  7.5.2 Holostem Terapie Avanzate S.r.l. Business Overview
  7.5.3 Holostem Terapie Avanzate S.r.l. Stem Cell Treatments Major Product Offerings
  7.5.4 Holostem Terapie Avanzate S.r.l. Stem Cell Treatments Revenue in Global Market (2017-2022)
  7.5.5 Holostem Terapie Avanzate S.r.l. Key News
7.6 Athersys Inc.
  7.6.1 Athersys Inc. Corporate Summary
  7.6.2 Athersys Inc. Business Overview
  7.6.3 Athersys Inc. Stem Cell Treatments Major Product Offerings
  7.6.4 Athersys Inc. Stem Cell Treatments Revenue in Global Market (2017-2022)
  7.6.5 Athersys Inc. Key News
7.7 CORESTEM, Inc
  7.7.1 CORESTEM, Inc Corporate Summary
  7.7.2 CORESTEM, Inc Business Overview
  7.7.3 CORESTEM, Inc Stem Cell Treatments Major Product Offerings
  7.7.4 CORESTEM, Inc Stem Cell Treatments Revenue in Global Market (2017-2022)
  7.7.5 CORESTEM, Inc Key News
7.8 Mesoblast Ltd.
  7.8.1 Mesoblast Ltd. Corporate Summary
  7.8.2 Mesoblast Ltd. Business Overview
  7.8.3 Mesoblast Ltd. Stem Cell Treatments Major Product Offerings
  7.8.4 Mesoblast Ltd. Stem Cell Treatments Revenue in Global Market (2017-2022)
  7.8.5 Mesoblast Ltd. Key News
7.9 Regenexx
  7.9.1 Regenexx Corporate Summary
  7.9.2 Regenexx Business Overview
  7.9.3 Regenexx Stem Cell Treatments Major Product Offerings
  7.9.4 Regenexx Stem Cell Treatments Revenue in Global Market (2017-2022)
  7.9.5 Regenexx Key News
7.10 Reliance Life Sciences Private Limited
  7.10.1 Reliance Life Sciences Private Limited Corporate Summary
  7.10.2 Reliance Life Sciences Private Limited Business Overview
  7.10.3 Reliance Life Sciences Private Limited Stem Cell Treatments Major Product Offerings
  7.10.4 Reliance Life Sciences Private Limited Stem Cell Treatments Revenue in Global Market (2017-2022)
  7.10.5 Reliance Life Sciences Private Limited Key News
7.11 U.S. Stem Cell, Inc.
  7.11.1 U.S. Stem Cell, Inc. Corporate Summary
  7.11.2 U.S. Stem Cell, Inc. Business Overview
  7.11.3 U.S. Stem Cell, Inc. Stem Cell Treatments Major Product Offerings
  7.11.4 U.S. Stem Cell, Inc. Stem Cell Treatments Revenue in Global Market (2017-2022)
  7.11.5 U.S. Stem Cell, Inc. Key News
7.12 Vericel Corporation
  7.12.1 Vericel Corporation Corporate Summary
  7.12.2 Vericel Corporation Business Overview
  7.12.3 Vericel Corporation Stem Cell Treatments Major Product Offerings
  7.12.4 Vericel Corporation Stem Cell Treatments Revenue in Global Market (2017-2022)
  7.12.5 Vericel Corporation Key News
7.13 Pharmicell Co., Ltd
  7.13.1 Pharmicell Co., Ltd Corporate Summary
  7.13.2 Pharmicell Co., Ltd Business Overview
  7.13.3 Pharmicell Co., Ltd Stem Cell Treatments Major Product Offerings
  7.13.4 Pharmicell Co., Ltd Stem Cell Treatments Revenue in Global Market (2017-2022)
  7.13.5 Pharmicell Co., Ltd Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Stem Cell Treatments Market Opportunities & Trends in Global Market
Table 2. Stem Cell Treatments Market Drivers in Global Market
Table 3. Stem Cell Treatments Market Restraints in Global Market
Table 4. Key Players of Stem Cell Treatments in Global Market
Table 5. Top Stem Cell Treatments Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Stem Cell Treatments Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Stem Cell Treatments Revenue Share by Companies, 2017-2022
Table 8. Global Companies Stem Cell Treatments Product Type
Table 9. List of Global Tier 1 Stem Cell Treatments Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Stem Cell Treatments Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Stem Cell Treatments Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Stem Cell Treatments Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Stem Cell Treatments Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Stem Cell Treatments Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Stem Cell Treatments Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Stem Cell Treatments Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Stem Cell Treatments Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Stem Cell Treatments Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Stem Cell Treatments Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Stem Cell Treatments Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Stem Cell Treatments Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Stem Cell Treatments Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Stem Cell Treatments Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Stem Cell Treatments Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Stem Cell Treatments Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Stem Cell Treatments Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Stem Cell Treatments Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Stem Cell Treatments Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Stem Cell Treatments Revenue, (US$, Mn), 2023-2028
Table 30. Osiris Therapeutics, Inc Corporate Summary
Table 31. Osiris Therapeutics, Inc Stem Cell Treatments Product Offerings
Table 32. Osiris Therapeutics, Inc Stem Cell Treatments Revenue (US$, Mn), (2017-2022)
Table 33. MEDIPOST Co., Ltd Corporate Summary
Table 34. MEDIPOST Co., Ltd Stem Cell Treatments Product Offerings
Table 35. MEDIPOST Co., Ltd Stem Cell Treatments Revenue (US$, Mn), (2017-2022)
Table 36. JCR Pharmaceuticals Co., Ltd Corporate Summary
Table 37. JCR Pharmaceuticals Co., Ltd Stem Cell Treatments Product Offerings
Table 38. JCR Pharmaceuticals Co., Ltd Stem Cell Treatments Revenue (US$, Mn), (2017-2022)
Table 39. FUJIFILM Cellular Dynamics, Inc. Corporate Summary
Table 40. FUJIFILM Cellular Dynamics, Inc. Stem Cell Treatments Product Offerings
Table 41. FUJIFILM Cellular Dynamics, Inc. Stem Cell Treatments Revenue (US$, Mn), (2017-2022)
Table 42. Holostem Terapie Avanzate S.r.l. Corporate Summary
Table 43. Holostem Terapie Avanzate S.r.l. Stem Cell Treatments Product Offerings
Table 44. Holostem Terapie Avanzate S.r.l. Stem Cell Treatments Revenue (US$, Mn), (2017-2022)
Table 45. Athersys Inc. Corporate Summary
Table 46. Athersys Inc. Stem Cell Treatments Product Offerings
Table 47. Athersys Inc. Stem Cell Treatments Revenue (US$, Mn), (2017-2022)
Table 48. CORESTEM, Inc Corporate Summary
Table 49. CORESTEM, Inc Stem Cell Treatments Product Offerings
Table 50. CORESTEM, Inc Stem Cell Treatments Revenue (US$, Mn), (2017-2022)
Table 51. Mesoblast Ltd. Corporate Summary
Table 52. Mesoblast Ltd. Stem Cell Treatments Product Offerings
Table 53. Mesoblast Ltd. Stem Cell Treatments Revenue (US$, Mn), (2017-2022)
Table 54. Regenexx Corporate Summary
Table 55. Regenexx Stem Cell Treatments Product Offerings
Table 56. Regenexx Stem Cell Treatments Revenue (US$, Mn), (2017-2022)
Table 57. Reliance Life Sciences Private Limited Corporate Summary
Table 58. Reliance Life Sciences Private Limited Stem Cell Treatments Product Offerings
Table 59. Reliance Life Sciences Private Limited Stem Cell Treatments Revenue (US$, Mn), (2017-2022)
Table 60. U.S. Stem Cell, Inc. Corporate Summary
Table 61. U.S. Stem Cell, Inc. Stem Cell Treatments Product Offerings
Table 62. U.S. Stem Cell, Inc. Stem Cell Treatments Revenue (US$, Mn), (2017-2022)
Table 63. Vericel Corporation Corporate Summary
Table 64. Vericel Corporation Stem Cell Treatments Product Offerings
Table 65. Vericel Corporation Stem Cell Treatments Revenue (US$, Mn), (2017-2022)
Table 66. Pharmicell Co., Ltd Corporate Summary
Table 67. Pharmicell Co., Ltd Stem Cell Treatments Product Offerings
Table 68. Pharmicell Co., Ltd Stem Cell Treatments Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Stem Cell Treatments Segment by Type in 2021
Figure 2. Stem Cell Treatments Segment by Application in 2021
Figure 3. Global Stem Cell Treatments Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Stem Cell Treatments Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Stem Cell Treatments Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Stem Cell Treatments Revenue in 2021
Figure 8. By Type - Global Stem Cell Treatments Revenue Market Share, 2017-2028
Figure 9. By Application - Global Stem Cell Treatments Revenue Market Share, 2017-2028
Figure 10. By Region - Global Stem Cell Treatments Revenue Market Share, 2017-2028
Figure 11. By Country - North America Stem Cell Treatments Revenue Market Share, 2017-2028
Figure 12. US Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Stem Cell Treatments Revenue Market Share, 2017-2028
Figure 16. Germany Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 17. France Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Stem Cell Treatments Revenue Market Share, 2017-2028
Figure 24. China Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 28. India Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Stem Cell Treatments Revenue Market Share, 2017-2028
Figure 30. Brazil Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Stem Cell Treatments Revenue Market Share, 2017-2028
Figure 33. Turkey Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Stem Cell Treatments Revenue, (US$, Mn), 2017-2028
Figure 37. Osiris Therapeutics, Inc Stem Cell Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. MEDIPOST Co., Ltd Stem Cell Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. JCR Pharmaceuticals Co., Ltd Stem Cell Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. FUJIFILM Cellular Dynamics, Inc. Stem Cell Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Holostem Terapie Avanzate S.r.l. Stem Cell Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Athersys Inc. Stem Cell Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. CORESTEM, Inc Stem Cell Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Mesoblast Ltd. Stem Cell Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Regenexx Stem Cell Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Reliance Life Sciences Private Limited Stem Cell Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. U.S. Stem Cell, Inc. Stem Cell Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Vericel Corporation Stem Cell Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Pharmicell Co., Ltd Stem Cell Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)